Psychedelic therapeutics stocks
Heavily traded in Psychedelic therapeutics
Turnover over $10M/day5 of about 20 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| MMEDMiniMed Group, Inc. | $24.81M | +18.82% | Nov 16, 2026 |
| DFTXDefinium Therapeutics, Inc. | $70.25M | +321.47% | Nov 5, 2026 |
| ATAIAtaiBeckley Inc. | $67.49M | +58.06% | Nov 12, 2026 |
| CMPSCOMPASS Pathways plc | $40.43M | +182.88% | Nov 3, 2026 |
| HELPCybin D/B/A Helus Pharma | $19.47M | +126.46% | Nov 12, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
15 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | $6.18B | Mid cap | +18.82% |
| DFTX | Definium Therapeutics, Inc. | $5.41B | Mid cap | +321.47% |
| ATAI | AtaiBeckley Inc. | $2.73B | Mid cap | +58.06% |
| CMPS | COMPASS Pathways plc | $2.01B | Mid cap | +182.88% |
| GHRS | GH Research PLC | $1.91B | Small cap | +112.74% |
| HELP | Cybin D/B/A Helus Pharma | $994.48M | Small cap | +126.46% |
| CAQ | Cambridge Acquisition Corp. | $312.56M | Small cap | +0.80% |
| ENP.AX | Entropy Neurodynamics Limited | $46.61M | Micro cap | +8.11% |
| IXHL | Incannex Healthcare Inc. | $39.36M | Micro cap | −79.27% |
| EMD.AX | Emyria Limited | $30.49M | Micro cap | −2.04% |
| PBM | Psyence Biomedical Ltd. | $22.89M | Micro cap | −95.94% |
| ENVB | Enveric Biosciences, Inc. | $6.62M | Micro cap | −86.88% |
| XTLB | XTL Biopharmaceuticals Ltd. | $5.97M | Micro cap | −49.38% |
| SILO | Silo Pharma, Inc. | $3.63M | Micro cap | +158.43% |
| CMND | Clearmind Medicine Inc. | $1.40M | Micro cap | −99.77% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 15 companies grouped under the Psychedelic therapeutics theme. The median market value in the group is $46.61M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −92.3% to +173.1% across the middle 80 percent of the group, with a median of +8.1%.